Market World Thyroid Gland Disorder Treatment Market Key Region | Page 2

Further, benign nodules do not commonly affect the patient’s health and these nodules occur in
cases of abnormal cell growth. These nodules can put a pressure on the neck and end up the patient
in some serious troubles such as swallowing, breathing and speaking if the size of benign appears to
be too large. A thyroid gets triggered in the presence of such nodules.
Driving factors responsible for the growth of thyroid gland disorder treatment market includes rise
in patients with iodine deficiency. Additionally, with invention of new drug technologies, the
companies are now focusing on enhanced drug formulation using novel drug delivery technologies.
Based on segmentation by disease type, the thyroid gland disorder treatment market includes
hypothyroidism and hyperthyroidism. Based on segmentation by drug type, the thyroid gland
disorder treatment industry includes levothyroxine, propacil, liothyronine, and imidazole.
Geographically, thyroid gland disorder treatment market spans North America, Latin America,
Europe, Asia-Pacific, Middle-East and Africa. North America and Europe market is expected to gain a
positive traction in the forthcoming period owing to increase in R&D techniques and better medical
infrastructure. APAC and MEA market is anticipated to grow at a higher CAGR owing to higher
prevalence of thyroid. Other factors such as low medical infrastructure and less favorable medical
diagnoses in emerging countries is likely to contribute to the market growth. The key players in the
thyroid gland disorder treatment market include AbbVie, Pfizer Inc, Merck & Co Inc, Allergan plc,
Mylan N.V. GlaxoSmithKline Plc, Novartis AG, RLX LABS Inc, Sanofi S.A, and Abott Laboratories.
Request Sample Copy of this Market Research @
https://www.millioninsights.com/industry-reports/thyroid-gland-disorder-treatment-market/request-sample
Market Segment:
Geographically, this report is segmented into several key Regions, with production, consumption,
revenue (million USD), market share and growth rate of Thyroid Gland Disorders Treatment in
these regions, from 2012 to 2022 (forecast), covering
• North America
• Europe
• China
• Japan